Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Capricor Therapeutics, Inc.
Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.
IPO Date: March 1, 2007
Sector: Healthcare
Industry: Biotech
Market Cap: $327.95M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.18 | 3.95%
Avg Daily Range (30 D): $0.57 | 5.48%
Avg Daily Range (90 D): $0.60 | 5.70%
Institutional Daily Volume
Avg Daily Volume: .64M
Avg Daily Volume (30 D): 3.02M
Avg Daily Volume (90 D): 2.32M
Trade Size
Avg Trade Size (Sh.): 186
Avg Trade Size (Sh.) (30 D): 132
Avg Trade Size (Sh.) (90 D): 112
Institutional Trades
Total Inst.Trades: 306
Avg Inst. Trade: $1.35M
Avg Inst. Trade (30 D): $1.1M
Avg Inst. Trade (90 D): $1.13M
Avg Inst. Trade Volume: .12M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.5M
Avg Closing Trade (30 D): $1.32M
Avg Closing Trade (90 D): $1.24M
Avg Closing Volume: 127.25K
   
News
Jul 22, 2025 @ 6:57 PM
ROSEN, LEADING INVESTOR COUNSEL, Encourages Capric...
Source: Rosen Law Firm
Jul 19, 2025 @ 2:31 PM
CAPRICOR ALERT: Bragar Eagel & Squire, P.C. Announ...
Source: Bragar Eagel & Squire, P.C.
Jul 18, 2025 @ 5:50 PM
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates ...
Source: James (Josh) Wilson
Jul 18, 2025 @ 4:56 PM
CAPRICOR THERAPEUTICS, INC. (NASDAQ: CAPR) INVESTO...
Source: Bernstein Liebhard Llp
Jul 17, 2025 @ 10:37 PM
Shareholder Alert: Robbins LLP Informs Investors o...
Source: Robbins Llp
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-.53 $-.11 $-1.15
Diluted EPS $-.53 $-.11 $-1.15
Revenue $ M $ 11.13M $ 22.27M
Gross Profit $ $ $
Net Income / Loss $ -24.39M $ -7.12M $ -40.47M
Operating Income / Loss $ -24.98M $ -7.7M $ -42.56M
Cost of Revenue $ $ $
Net Cash Flow $ 17.51M $ -57.09M $ -3.41M
PE Ratio    
Splits
Jun 05, 2019:   1:10
Nov 21, 2013:   1:50
Feb 09, 2007:   1:10
Apr 05, 2005:   1:20